Monday, June 15, 2026

Xi, Putin, Kim to Share Tiananmen Rostrum for Victory Day, First Trilateral Display in 66 Years

Kim Jong Un joins Xi Jinping and Putin in Beijing for Victory Day, marking the first trilateral meeting since 1959.

SBE303: The Next-Gen ADC Cancer Drug Revolutionizing Treatment in 2026

Samsung Bioepis presents promising results for SBE303, a next-gen ADC targeting nectin-4, showing improved efficacy and safety in trials.

RLWRLD Appoints Carl Choi as U.S. Head: What This Means for AI Robotics in 2026

RLWRLD appoints Carl Choi as U.S. representative to enhance market entry and partnerships in AI and robotics sectors.

Tag: Keytruda

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Alteogen Secures U.S. Patent for Keytruda Subcutaneous Injection: What This Means for ALT-B4 and Future Treatments

Alteogen secures a U.S. patent for a subcutaneous Keytruda formulation using ALT-B4, ensuring exclusivity until 2043 and potential $1B in sales.

How Keytruda is Revolutionizing Cancer Treatment: Expanded Coverage for Stomach Cancer in 2026

Keytruda's insurance coverage expands to stomach cancer, solidifying its status as a leading universal immunotherapy for various cancers.

Opdivo Wins EU Approval in Big Step for Early Lung Cancer Treatment

Opdivo gains EU approval for perioperative therapy in NSCLC, enhancing competition with Keytruda and marking a treatment paradigm shift.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.